Biokraft International AB

OM:BIOGAS Stock Report

Market Cap: SEK 880.3m

Biokraft International Past Earnings Performance

Past criteria checks 0/6

Biokraft International's earnings have been declining at an average annual rate of -15%, while the Oil and Gas industry saw earnings growing at 27% annually. Revenues have been growing at an average rate of 5.8% per year.

Key information

-15.0%

Earnings growth rate

25.1%

EPS growth rate

Oil and Gas Industry Growth-0.6%
Revenue growth rate5.8%
Return on equity-27.2%
Net Margin-34.1%
Next Earnings Update31 May 2024

Recent past performance updates

Recent updates

There's Been No Shortage Of Growth Recently For Scandinavian Biogas Fuels International's (STO:BIOGAS) Returns On Capital

Mar 23
There's Been No Shortage Of Growth Recently For Scandinavian Biogas Fuels International's (STO:BIOGAS) Returns On Capital

Revenue & Expenses Breakdown

How Biokraft International makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:BIOGAS Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23469-1602230
30 Sep 23443-1172090
30 Jun 23419-1011930
31 Mar 23402-1301860
31 Dec 22387-821820
30 Sep 22378-651780
30 Jun 22395-531780
31 Mar 22407-381720
31 Dec 21414-341660
30 Sep 21414-471530
30 Jun 21387-541440
31 Mar 21359-601360
31 Dec 20356-571290
30 Sep 20368-521270
30 Jun 20374-531270
31 Mar 20385-361270
31 Dec 19376-431270
30 Sep 19364-501510
30 Jun 19339-791470
31 Mar 19314-801510
31 Dec 18288-901500
30 Sep 18270-1051350
30 Jun 18269-831410
31 Mar 18271-841330
31 Dec 17274-691300
30 Sep 17279-551260
30 Jun 17277-471170
31 Mar 17272-381150
31 Dec 16259-461070
30 Sep 16253-43940
31 Dec 15228-16760

Quality Earnings: BIOGAS is currently unprofitable.

Growing Profit Margin: BIOGAS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIOGAS is unprofitable, and losses have increased over the past 5 years at a rate of 15% per year.

Accelerating Growth: Unable to compare BIOGAS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BIOGAS is unprofitable, making it difficult to compare its past year earnings growth to the Oil and Gas industry (-1.8%).


Return on Equity

High ROE: BIOGAS has a negative Return on Equity (-27.22%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/09 12:22
End of Day Share Price 2024/04/09 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biokraft International AB is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adrian Gilani GöranssonABG Sundal Collier Sponsored